Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Our commitment to pioneering novel oral synthetic cannabinoid combination therapeutics and our oral synthetic psilocybin treatment remains strong, and we look forward to sharing further updates in the ...

The Philomath City Council continued its review of psilocybin regulation options during its regular monthly meeting Tuesday and approved two draft ordinances.

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing ...

If the Colorado Springs City Council approves the zoning measure, it would essentially bar the centers from operating in ...

However, not everyone with depression will be eligible for this innovative treatment. The study, led by researchers from ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

It is also the psychiatric illness that holds the record for having the highest mortality rate. The UCSD research explores ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...